Kevin Sloan

VP, Development Programs & Program Leader at Alnylam Pharmaceuticals

Role
Vice President, Development Programs & Program Leader (R & d) at Alnylam Pharmaceuticals
Location
Cambridge, MA, US
LinkedIn followers
500 followers

About Kevin Sloan

Experienced R&D leader with a passion for applied science, early-stage drug development and patient impact. Proven track record leading cross-functional program teams as well as direct line management of key functional areas. Results-driven problem solver with exceptional communication skills and a broad background spanning research, development and commercial perspectives. Able to move quickly between big-picture strategic thinking and deep technical detail to integrate creative solutions. Breadth of experience across multiple platform modalities (small molecules, antibodies, RNAi, CRISPR gene editing) in start-up, clinical-stage & commercial-stage companies. Experience leading early pipeline portfolios and collaborations as well as individual development programs from research through clinical proof of concept across a range of indication areas.

Experience

  1. Vice President, Development Programs & Program Leader (R & d)

    Alnylam Pharmaceuticals

    Apr 2018 — Present · Cambridge, MA, US

    Seasoned R&D / translational leader; routinely integrating across research, clinical & commercial perspectives to advise & prioritize emerging projects• Program Leader driving strategy & cross-functional team leadership for multiple development-stage assets spanning nonclinical through early clinical development (IND/CTA-enabling through Ph1/Ph2 proof-of-concept)• Experience leading R&D programs across a variety of indication areas & sizes; currently leading programs in Alzheimer’s, Huntington’s, & NASH/NAFLD; led COVID19 program during pandemic• Partnering internally & externally with key stakeholders across research, nonclinical, clinical & commercial functions; routinely collaborating with C-suite executives• Member of early development governance board & company-wide senior leadership team

Education

  • Tufts University School of Medicine

    Ph.D., Cell & Molecular Biology; focus: proteomics / target discovery & cancer cell biology

  • Macalester College

    B.A., Biology; focus: neuroscience

  • Boston University

    M.A., Biology; focus: neuroscience & neurodegenerative disease

Skills

  • Contracts
  • Clinical Trials
  • Oncology
  • Lifesciences
  • Proteomics
  • Drug Development
  • Biomarkers
  • Molecular Biology
  • Cell Biology
  • Assay Development
  • Glp
  • Project Leadership
  • Due Diligence
  • Drug Discovery
  • Outsourcing
  • Leadership
  • Biotechnology
  • Life Sciences
  • Pharmacogenetics
  • Alliance Management
  • External Relationships
  • Translational Medicine
  • Clinical Development
  • Neuroscience
  • Pharmaceutical Industry
  • Clia
  • Personalized Medicine
  • Program Management

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Kevin Sloan — Vice President, Development Programs & Program Leader (R & d) at Alnylam Pharmaceuticals in Cambridge, MA, US | Unifers